Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 37% ± 15% | |
brain | 18 studies | 38% ± 19% | |
peripheral blood | 17 studies | 39% ± 11% | |
eye | 11 studies | 34% ± 11% | |
intestine | 10 studies | 28% ± 12% | |
kidney | 9 studies | 30% ± 11% | |
liver | 7 studies | 40% ± 20% | |
bone marrow | 5 studies | 36% ± 15% | |
heart | 5 studies | 22% ± 6% | |
lymph node | 5 studies | 40% ± 15% | |
pancreas | 4 studies | 50% ± 24% | |
uterus | 4 studies | 45% ± 14% | |
breast | 4 studies | 29% ± 7% | |
adipose | 4 studies | 30% ± 4% | |
placenta | 3 studies | 41% ± 5% | |
esophagus | 3 studies | 35% ± 24% | |
prostate | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 13370.62 | 459 / 459 | 100% | 267.29 | 1118 / 1118 |
esophagus | 100% | 12441.18 | 1445 / 1445 | 100% | 176.94 | 183 / 183 |
intestine | 100% | 11899.70 | 966 / 966 | 100% | 202.57 | 527 / 527 |
lung | 100% | 11664.27 | 578 / 578 | 100% | 194.52 | 1155 / 1155 |
ovary | 100% | 13030.39 | 180 / 180 | 100% | 198.16 | 430 / 430 |
thymus | 100% | 12903.07 | 653 / 653 | 100% | 213.13 | 604 / 605 |
bladder | 100% | 13675.19 | 21 / 21 | 100% | 192.18 | 503 / 504 |
prostate | 100% | 10031.77 | 245 / 245 | 100% | 172.64 | 501 / 502 |
skin | 100% | 16531.24 | 1809 / 1809 | 100% | 234.17 | 471 / 472 |
liver | 100% | 6748.94 | 226 / 226 | 100% | 112.34 | 405 / 406 |
stomach | 100% | 9669.08 | 359 / 359 | 100% | 183.48 | 285 / 286 |
uterus | 100% | 13819.94 | 170 / 170 | 100% | 209.46 | 457 / 459 |
brain | 99% | 7196.30 | 2620 / 2642 | 100% | 168.39 | 705 / 705 |
pancreas | 99% | 6382.82 | 324 / 328 | 100% | 173.50 | 178 / 178 |
kidney | 100% | 9504.61 | 89 / 89 | 98% | 149.74 | 885 / 901 |
adrenal gland | 100% | 10833.31 | 258 / 258 | 94% | 123.55 | 216 / 230 |
adipose | 100% | 12713.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13827.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 215.15 | 29 / 29 |
muscle | 100% | 9980.24 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12298.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 223.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 93.90 | 1 / 1 |
peripheral blood | 99% | 15798.09 | 918 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 183.83 | 78 / 80 |
heart | 97% | 7142.58 | 831 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0045087 | Biological process | innate immune response |
GO_0006302 | Biological process | double-strand break repair |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0006974 | Biological process | DNA damage response |
GO_0034462 | Biological process | small-subunit processome assembly |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0071425 | Biological process | hematopoietic stem cell proliferation |
GO_0043085 | Biological process | positive regulation of catalytic activity |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0000725 | Biological process | recombinational repair |
GO_0060218 | Biological process | hematopoietic stem cell differentiation |
GO_0071475 | Biological process | cellular hyperosmotic salinity response |
GO_0022008 | Biological process | neurogenesis |
GO_0070198 | Biological process | protein localization to chromosome, telomeric region |
GO_0071481 | Biological process | cellular response to X-ray |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_1904430 | Biological process | negative regulation of t-circle formation |
GO_0000723 | Biological process | telomere maintenance |
GO_0002218 | Biological process | activation of innate immune response |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0006310 | Biological process | DNA recombination |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0000783 | Cellular component | nuclear telomere cap complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005958 | Cellular component | DNA-dependent protein kinase-DNA ligase 4 complex |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0070418 | Cellular component | DNA-dependent protein kinase complex |
GO_0043564 | Cellular component | Ku70:Ku80 complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0070419 | Cellular component | nonhomologous end joining complex |
GO_0005634 | Cellular component | nucleus |
GO_0034511 | Molecular function | U3 snoRNA binding |
GO_0003677 | Molecular function | DNA binding |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0051575 | Molecular function | 5'-deoxyribose-5-phosphate lyase activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0045027 | Molecular function | DNA end binding |
GO_0003691 | Molecular function | double-stranded telomeric DNA binding |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | XRCC5 |
Protein name | Uncharacterized protein XRCC5 X-ray repair cross complementing 5 X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)) |
Synonyms | G22P2 |
Description | FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA . Required for double-strand break repair and V(D)J recombination . Also has a role in chromosome translocation . The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner . It works in the 3'-5' direction . During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and binds to the broken ends of the DNA and protects them from further resection . Binding to DNA may be mediated by XRCC6 . The XRCC5-XRRC6 dimer acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold . The XRCC5-XRRC6 dimer is probably involved in stabilizing broken DNA ends and bringing them together . The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step . The XRCC5-XRRC6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks . XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined . The XRCC5-XRRC6 dimer together with APEX1 acts as a negative regulator of transcription . In association with NAA15, the XRCC5-XRRC6 dimer binds to the osteocalcin promoter and activates osteocalcin expression . As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome . Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome . Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . . |
Accessions | H7C0H9 Q53TC2 ENST00000392133.7 P13010 ENST00000417391.1 ENST00000392132.7 ENST00000451695.5 Q53T09 C9JZ81 |